A Structurally Stabilized Lipopolymer Nanoplatform Targeting Pan‐Tissue Antigen‐Presenting Cells Enables Durable in situ mRNA Cancer Immunotherapy

Journal:
Advanced Materials
Published:
DOI:
10.1002/adma.202520594
Affiliations:
4
Authors:
12
Go to article
Institutions Authors Share
Sun Yat-sen Memorial Hospital, SYSU, China
6.500000
 0.54
Hunan University of Science and Technology (HNUST), China
3.000000
 0.25
State Key Laboratory of Polymer Science and Technology, CIAC CAS, China
2.000000
 0.17
Second Affiliated Hospital, USC, China
0.500000
 0.04
Interested in Medical Biotechnology?